BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study-Reference-Cited by-同舟云学术

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study

Published:2007-06 Issue:3 Volume:16 Page:280-292
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Musolino Antonino,Bella Maria A.,Bortesi Beatrice,Michiara Maria,Naldi Nadia,Zanelli Paola,Capelletti Marzia,Pezzuolo Debora,Camisa Roberta,Savi Mario,Neri Tauro M.,Ardizzoni Andrea

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference35 articles.

1. BRCA-associated breast cancer in young women;Robson;J Clin Oncol,1998

2. Risks of cancer in BRCA 1-mutation carriers;Ford;Lancet,1994

3. The risk of cancer associated with specific mutations of BRCA 1 and BRCA 2 among Ashkenazi Jews;Struewing;N Engl J Med,1997

4. Differential contributions of BRCA 1 and BRCA 2 to early-onset breast cancer;Krainer;N Engl J Med,1997

5. Distinct molecular pathogeneses of early-onset breast cancers in BRCA 1 and BRCA 2 mutation carriers: a population-based study;Armes;Cancer Res,1999

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer;Cancer Letters;2024-09

2. Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets;Cancers;2024-03-13

3. Comparison of poly (ADP-ribose) polymerase inhibitors (PARPis) as maintenance therapy for newly-diagnosed and platinum-sensitive recurrent ovarian cancer with BRCA mutational status: a systematic review and network meta-analysis;Expert Review of Anticancer Therapy;2024-01-04

4. Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer;Annals of Surgical Oncology;2023-10-05

5. Updated Austrian treatment algorithm for metastatic triple-negative breast cancer;Wiener klinische Wochenschrift;2023-09-08